#ChatsWithChaudhrey the Podcast

Rizwan Chaudhrey

Chats with experts across the world of Life Science, Pharma and Bio-Pharma on all things related to Drug Discovery, Development, Manufacturing, Leadership, Entrepreneurship, Marketing, Events and other topics I love talking about!

  1. 🎧 #ChatsWithChaudhrey 𝐭𝐡𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 🎧 S6E02 #ReflectionsandForecasts2526 E02 with Biosynth Philip Noone Jan 13th 2026

    3D AGO

    🎧 #ChatsWithChaudhrey 𝐭𝐡𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 🎧 S6E02 #ReflectionsandForecasts2526 E02 with Biosynth Philip Noone Jan 13th 2026

    I was delighted to sit down with Philip Noone. CDir Executive Vice President Diagnostics at Biosynth as part of this years #ReflectionsandForecasts 2025/26 interview series, where I look back on the past year and look ahead to this. I asked Philip....... ◉ 01:08 Who are Biosynth and what is your role? 2025 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 ◉ 02:12 What's been happening in Biosynth Diagnostics part of the business – what were the highlights for you?  ◉ 06:06 Are there are other materials you are looking to develop other #recombinant alternatives to?  ◉ 07:19 Tell more about some of the other developments at Biosynth in 2025? ◉ 09:21 What are the main challenges your customers have faced in 2025? ◉ 11:59 Are there major differences in the regulatory environments in the different geographic regions ◉ 11:59 What were the main challenges your customers faced in 2025? ◉ 14:39 How much of a impact has #Sustainability and #AI had in the #IVD and #Diagnostics sector? ◉ 19:09 Is there anything other new developments you saw in 2025 that you would like to highlight to viewers? 2026 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 ◉ 21:56 Looking forward toward 2026, what are you thoughts in terms of how the market will be? ◉  24:28 What trends do you expect to see in 2026? ◉  27:10 What else can we expect from Biosynth in 2026? ◉  29:56 Finally what’s your New Year message to viewers? What are your thoughts on what Philip has said. Agree? Disagree? Whatever your views we would love to hear from you.  🎞 You can WATCH the podcast interview here https://lnkd.in/eTrnwawm 💻 You can learn more about Biosynth  using the link below and get in touch with Philip directly via LinkedIn! #RSKRF2526  #RSKBiosynth #diagnostics #biosynth #infectiousdiseases #Biotech #IVD #diagnosticreagents

    33 min
  2. 🎧  #ChatsWithChaudhrey  #ReflectionsandForecasts2526 E01 with Del Trezise, Chair ELRIG Jan 12th 2026

    JAN 29

    🎧 #ChatsWithChaudhrey #ReflectionsandForecasts2526 E01 with Del Trezise, Chair ELRIG Jan 12th 2026

    I had the pleasure to sit down with Del, ELRIG chair of the board before the Christmas break to kick of my #ReflectionsandForecasts2526 interview series. I asked Del.... ◉ 00:58 Quick overview of ELRIG and your history with ELRIG? ◉ 02:20 What is the role of Chair of the board and why you were happy to do it? 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 2025 ◉ 03:59 What have been some of the highlights for ELRIG this year? ◉ 06:48 I understand #DrugDisovery was a record breaking year this year? ◉ 07:39 You had your first event in the US this year. How did that go and what are your plans going forward? ◉ 09:41 How do think the market has been in 2025 for the UK and Europe? ◉ 12:10 What have seen as the hot topics in 2025 when putting together the event programs last year? 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 2026 ◉ 15:09 Looking ahead to 2026 what are your views from a macro level in terms of the Life Science sector in the UK and Europe? ◉ 18:01 What do you think Start-Ups are not doing to attract investors?  ◉ 21:10 Which technology trends apart from AI, and CGT which we discussed earlier people  should look out for? ◉ 25:27 What can we expect from ELRIG for 2026? What are your thoughts on what Del said re 2025 and 2026? Agree? Disagree? we would love to get your views.  🎞 You can WATCH the podcast interview here https://lnkd.in/eAJz55qy You can learn more about  ELRIG and all their upcoming events here https://elrig.org/ #RSKELRIG #RSKRF2526 #RSKJan26

    31 min
  3. #ChatsWithChaudhrey The Podcast S5E02 #ReflectionsAndForecasts 2024/2025 E2 with CellReady™’s COO Ignacio Núñez

    04/22/2025

    #ChatsWithChaudhrey The Podcast S5E02 #ReflectionsAndForecasts 2024/2025 E2 with CellReady™’s COO Ignacio Núñez

    I caught up with Ignacio in Jan to get his thoughts and predictions on what is happening in the #CellandGeneTherapy space and learn more about #CellReady I asked Ignacio ... ◉  Before we look back at 2024 Ignacio would you mind giving viewers a quick overview of CellReady, who you are and what your companies products/services are? 00:58 ◉ Who are G-Rex and what is the relationship between CellReady and ScaleReady? 01:46 ◉  First question re 2024, Ignacio how would you describe 2024 in one word and why?02:45 ◉ What have been some of the highlights for CellReady this year? 05:16 ◉ What challenges has the industry faced this year? 06:28 ◉ What are some of the key trends you have seen in #CellandGeneManufacturing? 10:29  Looking ahead to 2025 ◉ On a macro level how positive are you with regards investment in the #CGT space? 12:33 ◉ What challenges to you think the sector faces in the coming year? 14:10 ◉ Anything new in terms of innovation or trends we should be looking out for? 15:57 ◉ What can we expect from CellReady in 2025? 18:28 ◉ Where can people meet CellReady in the near future? 19:53 ◉ Finally, what is your message for viewers watching this for 2025? 21:12 🎞 You can WATCH the interview here https://lnkd.in/eS7fU96y 💻 Learn more about ScaleReady and CellReady™ here https://lnkd.in/egKNJGC5 #RSKRF2425 #RSKJan25 #RSKCellReady #CellTherapy #Pharma #GeneTherapy #RegenerativeMedicine #AllianceforRegenerativeMedicine #BiotechInnovation #LifeSciences  #ResearchSupport #HoustonBiotech #CARTcellTherapy #Biotechnology #CancerResearch #AdvancedTherapies #Immunotherapy CellReady™ ScaleReady Wilson Wolf Manufacturing, LLC

    23 min
  4. S03E11 #ChatswithChaudhreyThePodcast #ReflectionsandForecasts 22/23 with CAI's Alice Redmond & David Shenberger 10th Feb 23

    04/22/2025

    S03E11 #ChatswithChaudhreyThePodcast #ReflectionsandForecasts 22/23 with CAI's Alice Redmond & David Shenberger 10th Feb 23

    I sat down with #CAI's VP Marketing and Consulting Services, David Shenberger and Chief Strategy Officer Alice Redmond to look back at 2022, and get some predictions for 2023 We discussed #consolidationofassets and pipelines, #ATMPS, #RegulatoryFrameworks, #AI #Pharma4.0, #ChatGPT, #pharmapricing, #outsourcing and a lot more. I asked.... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 • Can you give me a quick overview of CAI? 00:43 • One word to describe 2022 and why? 01:49 • What were some of CAI key achievements in 2022? 03:00 • Have clients expectations changed since the pandemic? 04:19 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:00 • Does the growth of ATMPS changed how they work with clients? 09:07 • Are there any areas you think the industry could improve? 10:36 2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 • What are your predictions for the #LifeSciences, #Pharma and #BioPharma in 2023? 12:06 • What developments and trends do you expect to see/predict for #PharmaManufacturing? 16:55 • What can we expect CAI in 2023? 17:44 • Finally, what last thoughts would you like to leave viewers with for 2023? 20:45 🎞 WATCH the interview here https://lnkd.in/eMWuGXmF Feel free to leave any questions or comments for Alice or David below. You can learn more about CAI at www.cagents.com

    23 min
  5. S03E10 #ChatsWithChaudhreyThePodcast #ReflectionsandForecasts 22/23 with American Association of Pharmaceutical Scientists (AAPS) Executive Director Tina Morris 9th Feb 23

    04/22/2025

    S03E10 #ChatsWithChaudhreyThePodcast #ReflectionsandForecasts 22/23 with American Association of Pharmaceutical Scientists (AAPS) Executive Director Tina Morris 9th Feb 23

    I caught up with Tina as part of my #ReflectionsandForecasts 22/23 interview series. we covered a huge range of topics, include, #SupplyChain, #AI, New Technologies, and lots more. Check it out! I asked Tina... 2022 Reflections • Can you give me a quick overview of AAPS? 01:30 • Has AAPS membership changed with the growth of #ATMPS? 02:52 • One word to describe 2022 and why? 05:04 • What were some of AAPS’s achievements in 2022? 06:36 • Did the pandemic force AAPS to become more of a 365 association rather than just a major annual event organiser? 08:49 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 10:13 • Did the visitor profile change for #PharmSci360 in 2022? 12:10 • Are there any areas you think the industry could improve? 14:42 2023 Forecasts • What are your predictions for BioPharma/ Pharma in 2023? 16:44 • What developments and trends do you expect to see/predict in the Drug Development? 18:57 • How important are Sustainability and AI as issues for AAPS members? 20:53 • What can we expect from AAPS in 2023? 25:26 • Finally, what last thoughts would you like to leave viewers with for 2023? 28:13 🎞 WATCH the interview here https://lnkd.in/enQNjFHM Please feel free to leave any questions or comments below . You can learn more about #AAPS and their upcoming events at www.aaps.org/ 🎞 Watch my interview with Tina at Octobers #PharmSci36022 here https://lnkd.in/eQdjrwyZ

    30 min
  6. S03 E07 #ChatsWithChaudhreyThePodcast #ReflectionsandForecasts 2022 23 with PharmaLex Ireland's Jane Lyons               Feb 7th 2023

    04/22/2025

    S03 E07 #ChatsWithChaudhreyThePodcast #ReflectionsandForecasts 2022 23 with PharmaLex Ireland's Jane Lyons Feb 7th 2023

    I sat down with Jane Lyons, Country Manager, PharmaLex Ireland, and  European Co-Ordinator for Quality Management and Compliance, as part of my ongoing #ReflectionsandForecasts 2022/23 interview series. We covered a wide range of topics including #Hybridworking, #Onshoring, #BREXIT, #ATMPS, #AI, #Blockchain, #ANNEX1, #outsourcing and more. I asked her.... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬  •   Can you give me a quick overview of #PharmaLex? 00:55 •   One word to describe 2022 and why? 02:04 •   What were some of #PharmalexIrelands key achievements in 2022? 03:10 •    What has been client reactions to PharmaLex's continuing the hybrid working model 04:42 •   Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:24 •    How easy it for countries to onshore their #Pharma #API manufacturing? 07:52 •    How much impact has BREXIT had on Pharma in the UK and Europe? 08:59 •    Are there any areas you think the industry could improve? 10:37   2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 •   What are your predictions for the #LifeScience, #Pharma and #BioPharma in 2023? 12:16 •  What developments and trends do you expect to see/predict in terms of regulation?  14:11 •   What can we expect from Pharmalex Ireland in 2023? 16:19 •   What is Janes view in terms of funding in the Pharma/ BioPharma in Europe in 2023? 17:25 •  Finally, what last thoughts would you like to leave viewers with for 2023? 19:36 🎞 You WATCH the interview here https://lnkd.in/e6bX49r2 Please leave any questions or comments for Jane below.  You can find out more about PharmaLex Ireland at https://lnkd.in/dt_Fi9Vn You can also reach out to Jane via LinkedIn and email her at jane.lyons@pharmalex.com 🎞 You can see Janes Reflections and Forecasts for last year here  https://lnkd.in/eGtP9gxz

    22 min

About

Chats with experts across the world of Life Science, Pharma and Bio-Pharma on all things related to Drug Discovery, Development, Manufacturing, Leadership, Entrepreneurship, Marketing, Events and other topics I love talking about!